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Abstract 
 
Aims: 
The cardiac ryanodine receptor (RyR2), which mediates intracellular Ca2+ release to trigger 
cardiomyocyte contraction, participates in development of acquired and inherited 
arrhythmogenic cardiac disease. This study was undertaken to characterize the network of 
inter- and intra-subunit interactions regulating the activity of the RyR2 homotetramer. 
Methods and Results: 
We use mutational investigations combined with biochemical assays to identify the peptide 
sequence bridging the β8 with β9 strand as the primary determinant mediating RyR2 N-
terminus self-association. The negatively-charged side chains of two aspartate residues (D179 
and D180) within the β8-β9 loop are crucial for the N-terminal inter-subunit interaction. We 
also show that the RyR2 N-terminus domain interacts with the C-terminal channel pore region 
in a Ca2+-independent manner. The β8-β9 loop is required for efficient RyR2 subunit 
oligomerization but it is dispensable for N-terminus interaction with C-terminus. Deletion of 
the β8-β9 sequence produces unstable tetrameric channels with subdued intracellular Ca2+ 
mobilization implicating a role for this domain in channel opening. The arrhythmia-linked 
R176Q mutation within the β8-β9 loop decreases N-terminus tetramerization but does not 
affect RyR2 subunit tetramerization or the N-terminus interaction with C-terminus. RyR2R176Q 
is a characteristic hypersensitive channel displaying enhanced intracellular Ca2+ mobilization 
suggesting an additional role for the β8-β9 domain in channel closing. 
Conclusions: 
These results suggest that efficient N-terminus inter-subunit communication mediated by the 
β8-β9 loop may constitute a primary regulatory mechanism for both RyR2 channel activation 
and suppression. 
 
 
Translational Potential 
Our findings that the RyR2 β8-β9 loop is involved in both Ca2+ release channel opening and 
closing have important clinical implications. This RyR2 domain is a known “hot-spot” for 
mutations associated with arrhythmogenic cardiac disease, which could produce hypersensitive 
as well as hyposensitive channels. Therapeutic strategies currently focus on gain-of-function 
RyR2 channels to suppress sarcoplasmic reticulum Ca2+ release either indirectly with class I/II 
anti-arrhythmic drugs, or by directly targeting RyR2 to inhibit channel activity. These 
strategies may not only be ineffective, but they may exacerbate the malignant phenotype in the 
case of loss-of-function RyR2 mutations. 
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1. Introduction 
The ryanodine receptor (RyR), a homotetramer whose subunits each consists of ~5,000 amino 
acids, mediates sarcoplasmic reticulum (SR) Ca2+ release to enable excitation-contraction 
coupling.1 In mammalian adult heart, RyR2 is activated by Ca2+ influx through L-type voltage-
gated channels acting as a Ca2+ signal amplifier to initiate sarcomere contraction.2 Abnormal 
RyR2 gating perturbs cardiomyocyte Ca2+ handling resulting in acquired and inherited 
arrhythmogenic cardiac disease.3, 4 The recent determination of the RyR1 and RyR2 structures 
at near-atomic resolution by electron cryomicroscopy has been a major scientific breakthrough 
in the study of the Ca2+ release channel.5-10 For the first time, it has been possible to visualize 
not only secondary structural elements of the peptide backbone but also the position of amino 
acid side chains for the majority (~70%) of the RyR1/2 molecular mass. Structural comparison 
of the channel’s open and closed states reveals that RyR regulation is governed by extensive 
inter- and intra-subunit interactions. Amongst them, N-terminal inter-subunit interactions 
appear to be of paramount importance for the gating of the channel, a phenomenon also 
indicated by X-ray crystallography/computational docking11, 12 and demonstrated by 
biochemical/functional observations.13-15 
Here, we describe inter-domain contact sites and assess their role in the regulation of the RyR2 
channel. We propose that N-terminus self-association is the gatekeeper of RyR2 channel 
activity, instrumental in both the pore’s opening and closing mechanism. Robust N-terminal 
inter-subunit interactions maintain the wild-type channel closed, whereas modest disruption of 
N-terminus tetramerization results in a hypersensitive channel as seen with the pathogenic 
R176Q mutation. Severe disruption of N-terminus tetramerization due to deletion of the β8-β9 
loop, which also leads to impaired RyR2 tetramers, results in hyposensitive channels. 
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2. Methods 
 
2.1 Materials 
The human embryonic kidney (HEK) 293 cell line was obtained from ATCC® (CRL-1573), 
mammalian cell culture reagents and Fluo-3 AM were obtained from Thermo Scientific, 
CHAPS from Merck, protease inhibitor cocktail (CompleteTM) from Roche, nProtein-A 
Sepharose from GE Healthcare, electrophoresis equipment and reagents from Bio-Rad, 
enhanced chemiluminescence detection kit from Thermo Scientific, DNA restriction 
endonucleases from New England Biolabs, Pfu DNA polymerase from Promega, side-directed 
mutagenesis kit (QuikChange II XL) from Agilent Technologies, T7 Gene 6 Exonuclease from 
Affymetrix, oligonucleotides and all other reagents from Sigma unless otherwise stated.  
 
2.2 Plasmid construction 
The plasmid encoding for wild-type RyR2 N-terminus (NT, residues 1-906) tagged with the 
cMyc epitope at the N-terminus has been described previously.15 The 4-alanine substitution 
within the β13-β14 loop and the small 3-residue deletion within the β23-β24 loop (NTβ13-β14/4Ala 
and NTΔβ23-β24, respectively) were generated in NT using the side-directed mutagenesis 
QuikChange II XL kit and the complementary primers listed in Supplementary Table 1. Larger 
deletions (within the β8-β9, β20-β21 and β30-β31 loops) were generated using PCR 
amplification as described elsewhere.16 Briefly, primers were designed to contain four 
consecutive phosphorothioate residues located 12 nucleotides from the 5’end, which enabled 
digestion with T7 Gene 6 Exonuclease, thereby converting the blunt ends of the PCR product 
into 12-nucleotide 3’-end overhangs. In addition, the 6 outermost nucleotides of each primer 
were complementary to the 6 nucleotides of the reverse primer located immediately before the 
phosphorothioate residues, which resulted in self-circularization of the PCR product following 
exonuclease digestion. PCR was carried out using the side-directed mutagenesis kit, and the 
PCR product, firstly digested with DpnI followed by digestion with T7 Gene 6 Exonuclease, 
was transformed into bacteria to obtain plasmid DNA. Plasmid encoding for human RyR2Δβ8-
β9
 was prepared by replacing a SpeI–BstEII ~3.8kb fragment into the WT plasmid, whereas 
RyR2R176Q plasmid has previously been described.17 An RyR2 C-terminal fragment (residues 
3529-4967) was generated by PCR amplification from full-length human RyR2 cDNA and 
cloned into pCR3 (Thermo Scientific) containing an N-terminal HA epitope tag (HA-RyR2-
CT). All plasmid constructs were verified by direct DNA sequencing. 
 
2.3 Chemical cross-linking 
HEK293 cells were transiently transfected with plasmid DNA encoding for RyR2 NT 
constructs using TurboFect (Thermo Scientific) according to the provider’s instructions. 24 h 
post-transfection, cells were homogenized on ice in homogenization buffer (5 mM HEPES, 0.3 
M sucrose, 10 mM DTT, pH 7.4) by 20 passages through a needle (0.6 x 30 mm) and dispersing 
the cell suspension through half volume of glass beads (425-600 microns, Sigma). Cell nuclei 
and glass beads were removed by centrifugation at 1500 x g for 5 min at 4 °C. The supernatant 
obtained following a subsequent centrifugation step (20000 x g for 10 min at 4 °C) was retained 
and protein concentration was measured using the bicinchoninic acid (BCA) colorimetric assay 
(Thermo Scientific). Cell homogenate (20 g) was incubated with glutaraldehyde (0.0025% or 
260 mol/l) for the following time-points: 0 min, 2 min, 5 min, 10 min, 15 min, 20 min, 30 
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min and 1 h. The reaction was stopped with the addition of hydrazine (2%) and SDS-PAGE 
loading buffer (60 mM Tris, 2% SDS, 10% glycerol, 5 mM EDTA, 0.01% bromophenol blue, 
pH 6.8). Samples were analyzed by SDS-PAGE and immunoblotting with AbcMyc (mouse 
9E10, Santa Cruz Biotechnology; used at 1:1000 dilution). Tetramer to monomer ratio was 
determined by densitometry using a GS-900 Scanner (Bio-Rad) and Image Lab software (Bio-
Rad). Tetramer formation was calculated as follows: T=ODT/(ODT+ODM)x100, where ODT 
and ODM correspond to optical density obtained for tetramer and monomer bands respectively. 
Statistical analysis was carried out with GraphPad Prism software using Kruskal-Wallis test 
with Dunn’s multiple comparison test. 
 
2.4 Co-immunoprecipitation 
HEK293 cells were transiently co-transfected with plasmid DNA for HA-RyR2-CT (residues 
3529-4967 tagged with HA epitope) together with RyR2 NT constructs (residues 1-906 tagged 
with cMyc epitope) using TurboFect. 24 h post-transfection cells were homogenized on ice in 
buffer (20 mM Tris, 150 mM NaCl, pH 7.4) as described above.  Cell nuclei and glass beads 
were removed by centrifugation at 1500 x g for 5 min at 4 °C and the supernatant was incubated 
overnight at 4 °C in the presence of 0.5% CHAPS under rotary agitation. Following overnight 
solubilization and centrifugation at 20000 x g for 10 min at 4 °C to remove the insoluble 
material, the supernatant was incubated at 4 °C for 6 h with protein A sepharose beads (GE 
Healthcare) and 2 μg of AbHA (rabbit ab9110, Abcam) under rotary agitation (2 μg of normal, 
non-immune rabbit IgG (Santa Cruz Biotechnology) was used as negative control). Beads were 
recovered at 1500 x g for 2 min at 4 °C, washed two times (10 min at 4 °C) with the IP buffer 
(20 mM Tris, 150 mM NaCl, 0.5% CHAPS, pH 7.4) and proteins were eluted with SDS-PAGE 
loading buffer. A small amount (1/10th) of the IP samples was analyzed by SDS-PAGE and 
immunoblotting with AbHA (mouse 16B12, Biolegend; used at 1:1000 dilution) to assess HA-
RyR2-CT expression and immunoprecipitation. The rest (9/10th) of the IP samples was 
analyzed by SDS-PAGE and immunoblotting with AbcMyc (mouse 9E10, Santa Cruz 
Biotechnology; used at 1:1000 dilution) to assess the amount of the co-precipitated RyR2 NT 
construct. The amount of co-precipitated RyR2 NT proteins was determined by densitometry 
(using GS-900 Scanner and Image Lab software), normalized against the amount of the input 
protein in the lysate and specific binding was calculated by subtracting the non-immune IgG 
IP signal from the anti-HA IP signal. Statistical analysis was carried out using one-way Anova 
with Bonferroni's multiple comparisons test. 
 
2.5 Sucrose density gradient centrifugation 
HEK293 cells transiently transfected with full-length human RyR2 plasmid DNA using 
TurboFect were harvested after 24 h. Cells were resuspended (106 cells/ml) in hypo-osmotic 
homogenization buffer (20 mM Tris, 1 mM EDTA, pH 7.4, supplemented with protease 
inhibitors) and homogenized on ice by 20 passages through a needle (0.6 x 30 mm). Cell nuclei 
and unbroken cells were removed by centrifugation at 1500 x g for 5 min at 4 °C and the 
supernatant was subjected to centrifugation at 100000 x g for 1 h at 4 °C in order to obtain the 
microsomal fraction. Protein content was measured using the BCA assay and microsomes were 
solubilized for 1 h at 4 °C in high-salt buffer (1 M NaCl, 0.15 mM CaCl2, 0.1 mM EGTA, 25 
mM PIPES, 0.6% CHAPS, 0.3% phosphatidylcholine, 2 mM DTT, pH 7.4, supplemented with 
protease inhibitors) at a protein concentration of 2.5 mg/ml. The insoluble material was 
removed by centrifugation at 16000 x g for 10 min at 4 °C and the supernatant was layered 
onto a continuous (5 - 40%) sucrose density gradient prepared in buffer (300 mM NaCl, 25 
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mM Tris, 50 mM HEPES, 0.3 mM EGTA, 0.1 mM CaCl2, 0.3% CHAPS, 0.15% 
phosphatidylcholine, 2 mM DTT, pH 7.4, supplemented with protease inhibitors). The gradient 
was spun at 100000 x g for 16 h at 4 °C, fractions were collected, and sucrose concentration 
was measured using a refractometer. Protein distribution was analyzed by SDS-PAGE and 
immunoblotting with RyR2 Ab1093 (raised against human RyR2 residues 4454-4474; used at 
1:500 dilution) characterized previously.17-19 Densitometry analysis was performed (using GS-
900 Scanner and Image Lab software) and the amount of RyR2 in each fraction was normalized 
against the amount of input protein in the microsomes. 
 
2.6 [3H]ryanodine binding 
[3H]ryanodine binding was performed on HEK293 microsomes expressing RyR2WT or 
RyR2Δβ8-β9 in the presence of 100 M CaCl2 and 10 mM caffeine to promote maximum channel 
activation.  200 g of HEK293 microsomes were incubated at 37 °C for 2 h in the presence of 
8 nM [3H]ryanodine (Perkin-Elmer) in binding buffer (25 mM PIPES, 1 M KCl, 2 mM DTT, 
pH 7.4). Samples were vacuum filtered through glass-fiber filters (GF/F Whatman), incubated 
overnight in scintillation liquid (Ultima Gold, Perkin Elmer), and radioactivity (dpm) was 
quantified using a scintillation counter (Tri-Carb 2100 TR, Packard BioScience). Specific 
binding was calculated from total by subtracting non-specific binding (in the presence of 10 M non-radiolabelled ryanodine) from three separate experiments each performed in duplicate. 
 
2.7 Calcium imaging 
Single cell Ca2+ imaging of HEK293 cells expressing RyR2 was adapted from an assay 
developed by Chen and colleagues.20 Cells (~1 x 105) were seeded on poly-lysine coated glass 
bottom dishes (MatTek) and transiently transfected with plasmid DNA for full-length human 
RyR2 using Effectene (Qiagen) according to the manufacturer’s instructions. After 48 h, cells 
were loaded with Fluo-3 AM (10 M) for 1 h at 30 C and immersed in buffer (120 mM NaCl, 
25 mM HEPES, 5.5 mM glucose, 4.8 mM KCl, 1.3 mM CaCl2, 1.2 mM KH2PO4, 1.2 mM 
MgCl2, pH 7.4) for imaging at 37 C. RyR2-mediated spontaneous Ca2+ release events were 
monitored using a laser scanning confocal microscope (Leica SP5) and LAS-AF software 
(Leica Microsystems) with the following parameters: 20x magnification objective lens, 
excitation at 488 nm and fluorescence emission detected at 500-550 nm, 512 x 512 pixel 
resolution, 100 msec time interval and scanning speed of 400 Hz. Cells were imaged for 3 min 
(5 min when thapsigargin was applied) and acquired regions of interest representing global 
Ca2+ environments (typically ~50 μm2) were selected. A broad range of parametric values was 
calculated from experimental traces by home developed MATLAB (MathWorks) based 
software. Parameters include oscillatory amplitude, transient duration, frequency of events, 
caffeine response (10 mM caffeine-induced Ca2+ transient typically taken as indication of Ca2+ 
store content), and response to (1 μM) thapsigargin. The store Ca2+ content was calculated as 
the integral of the experimental time-series following administration of caffeine and 
thapsigargin. To account for the prolonged tail at the end of the measurement, an exponential 
decay function was fitted on each trace in order to evaluate the total Ca2+ release from stores. 
Statistical analysis was performed using Mann-Whitney test. 
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3. Results 
3.1 Identification of the N-terminus inter-subunit contact sites 
We have previously found that the RyR2 N-terminus (NT, residues 1-906) displays robust self-
association shown by yeast two-hybrid, co-immunoprecipitation (co-IP), gel filtration and 
chemical cross-linking assays.13-15 Previous X-ray crystallography and computational docking 
studies placed the four N-terminal domains immediately adjacent to each other at the center of 
full-length RyR111, 12 enabling visualization of putative contact sites. In particular, the peptide 
sequence connecting the β8 with the β9 strand (β8-β9 loop) on one subunit is in close physical 
proximity with the β23-β24 loop and possibly with the β13-β14 loop (which was not resolved 
in the crystal structure) on the adjacent subunit. Furthermore, the β20-β21 loop on one subunit 
may be within contact distance with the β20-β21 loop of a neighboring subunit. In order to 
empirically test the involvement of these sequences in RyR2 N-terminus tetramerization, we 
generated a number of discrete NT constructs with targeted small internal deletions for use in 
cross-linking assays (Supplementary Table 2). To ensure that the overall folding of the NT 
peptide is unaffected, deletion constructs did not involve complete removal of all the amino 
acids within the targeted loop but retained some residues sufficient to bridge the adjoining β 
sheets. In the case of the short 4-residue β13-β14 loop, removal of any of these four amino 
acids could potentially alter the local conformation of the surrounding β sheets, and therefore 
a 4-alanine substitution rather than deletion was generated. NT deletion constructs were 
expressed in HEK293 cells and reacted with glutaraldehyde, which creates stable bridges 
between pre-existing protein complexes, and oligomer formation was analyzed by Western 
blotting using AbcMyc (Figure 1A). Cross-linking of NTΔβ8-β9 resulted in the appearance of the 
tetramer, however its abundance was extremely low relative to NTWT. Collective data (n  6) 
following densitometry analysis demonstrated that deletion of the β8-β9 loop resulted in 
substantial reduction (by 79% at 60 min) of the tetramer compared to WT (Figure 1B). NTβ13-
β14/4Ala
, NTΔβ20-β21 and NTΔβ31-β32, the latter serving as negative control, produced oligomers to 
the same extent as NTWT, whereas deletion of the β23-β24 sequence resulted in reduced 
tetramer formation (by 39% at 60 min) that did not reach statistical significance compared to 
WT.  These findings suggest a supporting role for the β23-β24 loop and identify the β8-β9 loop 
as the primary structural determinant for RyR2 N-terminus self-association. 
To pinpoint specific residues within the β8-β9 loop mediating N-terminus self-association, we 
consulted the recent high-resolution electron cryomicroscopy structures of RyR1 and RyR2.5-
10
. In spite of slight differences between the RyR1 and RyR2 structures and the lack of 
resolution for the side chain of some residues, RyR2 amino acids Q168, D179 and D180 appear 
to lie at the inter-subunit interface (Supplementary Table 3). In particular, Q168 is in close 
proximity to the backbone of G239 (at the edge of the β13 strand) and the negatively-charged 
side chain of D400 (within the β23-β24 loop). D179 and D180 are near to the positively-
charged side chain of H398, hydrophobic side chain of M399 as well as the peptide bond 
between these two residues (within the β23-β24 loop). We therefore generated separate NT 
constructs with double alanine substitutions of residues K167+Q168, D179+D180 as well as 
E173+K174, the latter to serve as negative control for use in cross-linking assays (n = 8). As 
expected, NTE173A+K174A produced tetramers equivalent to NTWT demonstrating the specificity 
of our assay. Tetramer formation of NTK167A+Q168A was similar to WT suggesting that putative 
interactions of the polar residue Q168 are of low affinity. On the other hand, the 
D179A+D180A mutant significantly decreased (by 57% at 60 min) tetramer formation (Figure 
2). These results validate the data obtained with the β8-β9 loop deletion and demonstrate that 
the negatively-charged residues D179/D180 are necessary for efficient RyR2 N-terminus self-
association. 
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3.2 The β8-β9 loop is required for RyR2 subunit oligomerization but dispensable for N-
terminus interaction with C-terminus 
The near-atomic determination of the RyR1/2 structure revealed that sequences within the N-
terminus, including the β8-β9 loop, may form several interfaces with sequences within the 
“core solenoid” domain at the C-terminus.5-10 To reveal specific β8-β9 loop involvement in the 
putative N-terminus interaction with the pore-forming C-terminal region, we carried out co-IP 
experiments using HEK293 cells co-expressing NTWT or NTΔβ8-β9 together with HA-tagged 
RyR2-CT (residues 3529-4967). Assays were carried out in nominally zero Ca2+ (1 mM 
EGTA) or its presence (100 μM CaCl2) due to potential Ca2+-binding site(s) within the C-
terminus that may affect the interaction.5, 6, 8, 10 HA-RyR2-CT was immunoprecipitated with 
AbHA, verified by immunoblotting (Figure 3A, bottom panel), while the presence of co-
precipitated NTWT or NTΔβ8-β9 was analyzed by Western blotting using AbcMyc. NTWT was 
recovered in the HA immunoprecipitate but not in the negative control with non-immune rabbit 
IgG, irrespective of the presence (100 μM CaCl2) or absence (1 mM EGTA) of Ca2+ (Figure 
3A). Similarly, NTΔβ8-β9 was efficiently co-immunoprecipitated with HA-RyR2-CT under both 
Ca2+-free and Ca2+-containing conditions. Quantitative data (n = 6) indicated RyR2-CT 
interaction with NTΔβ8-β9 is comparable to that with NTWT, and that this is unaffected by the 
presence of Ca2+ (Figure 3B). These results indicate a Ca2+-independent interaction between 
the RyR2 N- and C-termini that does not require the presence of the β8-β9 loop. 
Given that N-terminus self-association is required for efficient oligomerization of full-length 
RyR2,13 we assessed the involvement of the β8-β9 sequence in RyR2 oligomerization by 
sucrose density gradient centrifugation. RyR2WT and RyR2Δβ8-β9 (amino acids 167-178 
removed) were expressed in HEK293 cells, CHAPS-solubilized microsomes were separated 
through linear 5-40% sucrose gradient, and gradient fractions were analyzed by Western 
blotting using Ab1093 (Figure 4). RyR2WT was predominantly found in “heavy” sucrose 
fractions (~28%) consistent with tetramer formation. In contrast, RyR2Δβ8-β9 was found 
distributed throughout the gradient, a sedimentation profile indicative of weakly-associated 
tetramers in equilibrium with dissociated subunits. 
 
3.3 The β8-β9 loop is required for RyR2 channel activation 
RyR2Δβ8-β9 function was investigated within the intact cellular milieu using confocal 
microscopy and Ca2+ imaging to monitor spontaneous Ca2+ oscillations.13, 21 Successful RyR2 
expression was verified by immunofluorescence using Ab1093 indicating comparable 
transfection efficiency for RyR2WT and RyR2Δβ8-β9 (Supplementary Figure 1). Cells expressing 
RyR2WT displayed the characteristic pattern of repetitive Ca2+ transients and also responded to 
suboptimal (1 mM) and maximal (10 mM) caffeine application (Figure 5). In contrast, cells 
expressing RyR2Δβ8-β9 exhibited very rare and diminished Ca2+ transients. Interestingly, 
RyR2Δβ8-β9-expressing cells had a similar response to WT when challenged with 1 mM caffeine 
but their response to maximal caffeine application was restrained compared to RyR2WT. The 
subdued RyR2Δβ8-β9 caffeine response did not allow for determination of the ER Ca2+ content, 
typically taken as the amplitude of the maximal caffeine-induced Ca2+ transient. To determine 
the relative ER Ca2+ content of cells expressing RyR2WT and RyR2Δβ8-β9, we used the 
suboptimal caffeine dose to sensitize RyR2 (1 mM, a dose that produced comparable response 
between WT and mutant) followed by (1 μM) thapsigargin (inhibitor of the SR/ER Ca2+ 
ATPase pump) to empty the ER Ca2+ store, which was measured by integration of the resultant 
cytosolic Ca2+ transient. The summary of the Ca2+ imaging data presented in Figure 5B 
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demonstrates that the RyR2 β8-β9 loop deletion drastically alters cellular Ca2+ cycling 
characteristics (Ca2+ transient amplitude, duration, frequency and ER Ca2+ store). First, Ca2+ 
transient amplitude was reduced compared to WT, despite higher ER Ca2+ store, which could 
indicate that RyR2Δβ8-β9 is unable to open fully. Second, there was a significant decrease in the 
number of spontaneous Ca2+ oscillations compared to WT. This observation combined with the 
inability of caffeine to trigger maximum activation of the channel suggest that RyR2Δβ8-β9 
exhibits profoundly altered sensitivity to agonists. Third, the ER Ca2+ store content was higher 
relative to WT, suggesting that RyR2Δβ8-β9 is much less prone to spontaneous channel opening 
than RyR2WT. Fourth, RyR2Δβ8-β9-expressing cells displayed a longer Ca2+ transient due to the 
larger Ca2+ store. These results indicate that residues 167-178 are crucial for RyR2 Ca2+ release. 
As an alternative assay to assess the caffeine response of RyR2Δβ8-β9, we used high-affinity 
[3H]ryanodine binding of microsomal membranes. Experiments were conducted using 
HEK293 microsomes expressing equal amounts of RyR2WT or RyR2Δβ8-β9 verified by 
immunoblotting (Supplementary Figure 2) in the presence of 100 μM Ca2+ and 10 mM caffeine 
to promote maximum channel activation. Despite an equal amount of RyR2 protein, the β8-β9 
loop deletion mutant displayed negligible [3H]ryanodine binding (2.0 ± 0.9 fmol/mg for 
RyR2Δβ8-β9 versus 30.6 ± 2.0 fmol/mg for RyR2WT, p < 0.01). Given that the caffeine and 
ryanodine-binding sites are located within the C-terminal transmembrane assembly,5 it is very 
unlikely that the small N-terminal deletion of residues 167-178 directly affects ligand binding. 
On the other hand, ryanodine (at nanomolar concentrations) binds only to intact RyR 
tetramers,22 which are compromised in RyR2Δβ8-β9 (Figure 4). Thus, the minute amount of 
bound [3H]ryanodine could only partly be due to diminished RyR2Δβ8-β9 response to agonists. 
3.4 The arrhythmogenic R176Q mutation within the β8-β9 loop reduces N-terminus 
tetramerization and produces gain-of-function channels 
To examine the involvement of the β8-β9 loop in RyR2 pathophysiology, we investigated the 
R176Q mutation linked with arrhythmogenic right ventricular dysplasia type 2 (ARVD2)23 as 
well as catecholaminergic polymorphic ventricular tachycardia (CPVT).24 Consistent with the 
results obtained with the β8-β9 loop deletion, chemical cross-linking analysis (n = 8) of 
NTR176Q indicated reduced N-terminus tetramer formation (by 58% at 60 min) compared to WT 
(Figure 6A), and co-IP assays (n ≥ 8) demonstrated HA-RyR2-CT binding for NTR176Q 
equivalent to NTWT (Figure 6B). However, unlike RyR2Δβ8-β9 tetrameric channels which were 
unstable, sucrose density gradient centrifugation (n = 4) of RyR2R176Q demonstrated full-length 
subunit oligomerization similar to WT (Figure 6C). These findings suggest that although the 
R176Q mutation disrupts N-terminus self-association, it has no effect on N-terminus 
interaction with C-terminus nor on RyR2 subunit oligomerization. 
The functional effects of the R176Q mutation were investigated by single cell Ca2+ imaging to 
monitor spontaneous Ca2+ oscillations in intact cells. In contrast to RyR2Δβ8-β9 that produced 
restrained intracellular Ca2+ mobilization, RyR2R176Q-expressing cells displayed prominent 
Ca2+ oscillations (Figure 7). Compared to WT, RyR2R176Q displayed a significant increase in 
the number of spontaneous Ca2+ transients with a concomitant smaller Ca2+ store, suggesting 
that the R176Q mutation results in hypersensitive and leaky channels. Ca2+ transient duration 
was smaller in RyR2R176Q-expressing cells most likely because there is less calcium available 
for release due to the smaller Ca2+ store. 
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4. Discussion 
The N-terminus domain of RyR2, one of the three arrhythmia-associated mutation hot-spots, 
is an important structural and functional regulatory element involved in both activation and 
termination of SR Ca2+ release.13, 15, 25-27 The present study significantly extends previous 
findings by structurally defining the primary interaction sites mediating N-terminus self-
association and also functionally demonstrates that the β8-β9 sequence is critically involved in 
RyR2 channel activity. 
 
4.1 The β8-β9 loop is the primary determinant for RyR2 N-terminal inter-subunit interactions 
High-resolution topological data11, 12 enabled us to target discrete domains, namely the peptide 
sequences connecting the β8 strand with β9, β13 with β14, β20 with β21, and β23 with β24. 
We found that deletion of the β8-β9 loop severely compromises RyR2 N-terminus 
tetramerization, whereas deletion of the β23-β24 sequence results in a modest decrease (Figure 
1). Conversely, deletion of the β20-β21 loop as well as the 4-alanine substitution within the 
β13-β14 loop are largely without effect. These findings suggest that the β8-β9 loop is the 
principal oligomerization determinant, with the β23-β24 loop having a supporting role. 
Residues within the β13-β14 and β20-β21 loops do not appear to play a prominent role in N-
terminus self-association, however, we cannot fully dismiss the contribution of these sequences 
due to limitations of our experimental approach. In particular, introduced deletions may not 
have been structurally disruptive due to compensatory structural rearrangements of 
neighboring residues. This kind of protein plasticity has been previously reported in RyR2 for 
the disease-causative deletion of exon 3.28 Alternatively, deletion of an individual domain may 
not have been detrimental to N-terminus oligomerization due to the presence of additional 
determinants. The recent near-atomic electron cryomicroscopy maps of RyR1 and RyR2 
confirm N-terminus tetrameric arrangement, which appears to be mediated through residues on 
a single inter-subunit interface that is qualitatively similar between these two RyR isoforms.7, 
9
 The contact interface is likely formed by residues within the β8-β9 loop (and within the β2 
sheet for RyR1 only) of subunit A, which are in close proximity (within 5 Å) with residues 
within the β13-β14 and β23-β24 loops (as well as within the β24 sheet for RyR1 only) of 
subunit B (Supplementary Table 3). Using alanine substitution mutagenesis of the β8-β9 
sequence, we found that the negatively-charged RyR2 residues D179 and D180, which are 
closely apposed to amino acids H398 and M399 within the β23-β24 loop, perturbed N-terminus 
tetramerization (Figure 2). Notably, the D179N mutation has been linked with 
catecholaminergic polymorphic ventricular tachycardia and the equivalent RyR1 residue 
(D166G and D166N) has been linked with malignant hyperthermia (Supplementary Figure 3), 
further highlighting the pivotal involvement of the negatively-charged side chain of this residue 
in N-terminus self-association. Thus, our empirical data together with the structural 
information demonstrate that the RyR2 N-terminal inter-subunit interaction is primarily 
mediated by amino acids 179-180 within the β8-β9 loop interacting with residues 398-399 
within the β23-β24 loop of an adjacent subunit. 
An additional finding of the present study is the demonstration of Ca2+-independent RyR2 N-
terminus interaction with the C-terminal region encompassing the pore-forming 
transmembrane segments and the preceding structural element termed “core solenoid”.5, 7, 9 We 
have previously shown an interaction between the isolated N-terminus and the extreme C-
terminal tail (residues 4867-4967) of RyR2,15 however, the latter is buried within the context 
of the full-length protein,5-10 and therefore this interaction does not confer physiological 
relevance for RyR2. Interestingly unlike RyR, the N-terminus and C-terminal tail of the related 
D
o
w
n
lo
a
d
e
d
 fro
m
 h
ttp
s
://a
c
a
d
e
m
ic
.o
u
p
.c
o
m
/c
a
rd
io
v
a
s
c
re
s
/a
d
v
a
n
c
e
-a
rtic
le
-a
b
s
tra
c
t/d
o
i/1
0
.1
0
9
3
/c
v
r/c
v
a
a
0
4
3
/5
7
4
1
4
1
1
 b
y
 C
a
rd
iff U
n
iv
e
rs
ity
 u
s
e
r o
n
 1
1
 M
a
rc
h
 2
0
2
0
CVR-2019-0689 
11 
 
inositol trisphosphate receptor calcium release channel – which have high peptide sequence 
and structural similarity with the corresponding RyR domains – are closely apposed in the 
context of the full-length channel, allowing for direct interaction to occur.29 In contrast, the 
high resolution RyR1/2 structures indicate extensive contacts (within 5 Å) between the N-
terminus and the core solenoid (residues 3620-4210).5, 7, 9 Interestingly, several disease-
causative RyR1/2 mutations reside at these interfaces, suggesting a pathogenic role for altered 
association between N- and C-termini. Notably, the β8-β9 interface with the core solenoid is 
largely unaltered in the transition from the closed to the open state of the RyR2 channel, 
whereas the β8-β9 interface with the neighboring N-terminus domain is widened in the open 
compared to the closed state7 (Supplementary Table 3). The results presented here are 
consistent with the structural information and further indicate that the recently identified, C-
terminal Ca2+-binding site5 is unlikely to affect N-terminus to C-terminus cross-talk. 
Importantly, the β8-β9 loop was found to be dispensable for N-terminus interaction with C-
terminus (Figure 3), and therefore its role in RyR2 channel function seems to be primarily 
mediated through the regulation of N-terminal inter-subunit interactions.  
The β8-β9 sequence is required not only for tetramerization of the N-terminus domain but also 
of the full-length RyR2 (Figure 4). This observation, which is consistent with our previous 
findings on the arrhythmogenic L433P mutation,13 highlights a crucial role for the N-terminal 
domain in RyR2 subunit oligomerization. Early work has demonstrated that the RyR C-
terminal region containing the transmembrane domains forms a tetrameric cation-conducting 
pore that binds ryanodine.30-32 Moreover, the extreme C-terminal tail not only forms tetramers 
by itself,33 it is also essential for RyR subunit tetramerization.34 These studies together with the 
present results indicate that both the N-terminus and C-terminus domains are necessary – but 
insufficient on their own – for efficient RyR tetramer assembly. 
 
4.2 The β8-β9 loop is indispensable for RyR2 function 
Notably, the β8-β9 loop is a key functional element indicated by the dysfunctional RyR2Δβ8-β9 
mutant. We found that deletion of residues 167-178 leads to defective channels that tend to 
remain inactive in living cells, indicated by subdued spontaneous Ca2+ oscillations in terms of 
both frequency and amplitude, and despite a higher ER Ca2+ content (Figure 5). These results 
are not surprising though, given that RyR2Δβ8-β9 displays reduced tetramer assembly with 
dissociated subunits unable to form Ca2+-conducting channels. The indispensable role of the 
β8-β9 sequence in channel function is highlighted by its extreme conservation across isoforms 
and species (including invertebrate RyR), as well as being the target of numerous RyR1/2 
mutations associated with skeletomuscular and cardiac disease (Supplementary Figure 3). 
In the present study we biochemically and functionally characterized the arrhythmogenic 
R176Q mutation within the β8-β9 loop in RyR2. In agreement with previous reports,35-37 we 
found that RyR2R176Q is a hypersensitive leaky channel displaying higher frequency of 
spontaneous Ca2+ transients and smaller intracellular Ca2+ store (Figure 7). To identify the 
molecular/structural defect(s), we carried out chemical cross-linking, co-immunoprecipitation 
and gradient centrifugation analyses (Figure 6). We found that the R176Q mutation has the 
following effects: 1) weakens N-terminus tetramerization, 2) has no effect on N-terminus 
interaction with C-terminus, and 3) has no effect on full-length RyR2 subunit oligomerization. 
These findings indicate that disruption of N-terminal inter-subunit interactions is the primary 
mechanism underlying gain-of-function RyR2R176Q. Consistent with our results, previous 
solution NMR and crystal structure studies showed that the R176Q mutation causes only local 
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structural perturbations within the β8-β9 sequence proposed to affect the N-terminus inter-
subunit interface.38 
At first sight, our functional observations for RyR2Δβ8-β9 and RyR2R176Q, namely loss-of-
function and gain-of-function channel, respectively, appear contradictory with each other. Both 
the β8-β9 deletion and R176Q mutation disrupt N-terminus tetramerization but the effect is 
more severe in the former, while neither manipulation alters N-terminus interaction with C-
terminus. Notably though, unlike the R176Q mutation, the β8-β9 deletion also impairs full-
length RyR2 subunit oligomerization, which accounts for the loss-of-function phenotype. 
Tellingly, the previously characterized L433P mutation, which also reduced both N-terminus 
tetramerization and full-length tetramer assembly, displayed both gain-of-function and loss-of-
function characteristics.13 A closer look at the chemical cross-linking data (at 60 min) suggests 
a gradual effect in N-terminus tetramerization efficiency, which is in turn linked to tetrameric 
channel assembly, with the two biochemical defects having contrasting functional effects. 
RyR2WT has robust N-terminus tetramerization stabilizing the closed conformation of intact 
tetrameric channels. Moderate disruption (by 58%) of N-terminus tetramerization but retaining 
intact full-length tetramers in RyR2R176Q, is manifested as a gain-of-function channel. Severe 
disruption (by 79%) of N-terminus tetramerization resulting in impairment of full-length 
tetramer assembly in RyR2Δβ8-β9, is manifested as loss-of-function channel. RyR2L433P with 
reduced (by 67%) N-terminus tetramerization and concomitant impairment of full-length 
tetramer assembly lies in between the two, displaying characteristics of both hypersensitive 
and hyposensitive channel.13  
Our present findings implying that the β8-β9 domain is involved in both opening and closing 
of the channel, are compatible with previous reports demonstrating that the N-terminus governs 
both activation and termination of SR Ca2+ release.13, 15, 25-27 Moreover, they have important 
clinical implications. While the vast majority of RyR2 mutations produce hypersensitive 
channels with increased diastolic SR Ca2+ leak resulting in delayed after-depolarisations, there 
is a handful of distinct RyR2 mutations including the ARVD2-linked L433P13, 37 and the 
hypertrophic cardiomyopathy-linked A1107M mutation reported to reduce Ca2+ release.27 In 
addition, the CPVT-linked A4860G mutation was found to depress RyR2 channel activity,39 
whereas ventricular myocytes from A4860G knockin mice had reduced amplitude of systolic 
Ca2+ release with overloaded SR Ca2+ content, which randomly caused bursts of prolonged 
systolic Ca2+ release triggering early after-depolarizations.40 Thus, it is conceivable that drugs 
that target gain-of-function RyR2 mutations, while beneficial for the majority of patients, may 
have deleterious effects on patients harbouring loss-of-function mutations. 
 
4.3 Limitations 
The present study made use of targeted removal of peptide loops connecting neighboring β 
strands and despite being designed following careful bioinformatics analysis of the available 
structural data, we cannot exclude the possibility of local or global conformational changes. 
The functional observations seen with deletion of residues 167-178 could be due to altered 
global conformation of the channel – although the remaining three residues within this loop 
would be expected to bridge the β8 and β9 strands. Moreover, the deletion did not affect the 
N-terminus interaction with the C-terminus arguing against global conformational 
destabilization. Thus, it is likely that RyR2Δβ8-β9 dysfunction is due to the specific loss of one 
of the contact sites at the N-terminus inter-subunit interface, which in turn perturbs the 
assembly of functional tetrameric channels. 
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The present work employed RyR2-expressing HEK293 cells because the study of genetically 
manipulated RyR2 is not feasible in the native context unless animal knockin models are 
available. At present, there is no efficient methodology to deliver the very large (~15 kb) RyR2 
cDNA inside cardiac myocytes, whereas gene editing is generally believed to be feasible only 
for actively dividing cells. A recent study has indicated that homology-directed repair is 
feasible in non-dividing cardiac myocytes in culture, however, gene editing was of low 
efficiency (up to 20-25%) for cardiac myocytes at neonatal stage, and it was not observed in 
adult cells.41 The RyR2-expressing HEK293 system is an experimental cellular assay that 
recapitulates spontaneous Ca2+ release under Ca2+ overload conditions in cardiac myocytes.20, 
42
 Enhancement of RyR2 activity with caffeine43, 44 or CPVT gain-of-function mutations  (e.g. 
R4496C)20, 45, 46 result in higher frequency of spontaneous Ca2+ transients and lower Ca2+ store 
content in both HEK293/RyR2 cells and cardiac myocytes. One discrepancy is that Ca2+ 
transient amplitude is largely unaffected in HEK293/RyR2 cells, whereas it is decreased in 
cardiac myocytes implicating the involvement of cardiac-specific accessory proteins.  
 
4.4 Summary 
We identify a short peptide sequence, which, although located remotely from the pore in terms 
of both primary and tertiary structure, is vital for RyR2 channel gating. The empirical findings 
presented in this study together with the known structural information allow us to draw a 
plausible hierarchical order of events leading to RyR2 channel activation (Graphical 
Abstract/Schematic Figure). Efficient inter-subunit N-terminus to N-terminus communication 
mediated by the β8-β9 loop is likely to constitute a primary signal for RyR2 gating. This may 
then be transmitted in a Ca2+-insensitive manner to the core solenoid domain via N-terminal 
sequences other than the β8-β9 residues, and subsequently conveyed on to the C-terminal 
channel domain to induce gating of the pore. Perturbation of N-terminal inter-subunit 
interactions, solely or in combination with impairment of RyR2 tetramer assembly, can lead to 
either gain-of-function or loss-of-function channels, respectively. 
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Figure Legends 
 
Figure 1: Deletion of the β8-β9 loop perturbs RyR2 N-terminus tetramerization 
Chemical cross-linking assays of HEK293 cell homogenates expressing NT (RyR2 residues 1-
906) WT or deletion mutants: NTΔβ8-β9 (residues 167-178 removed), NTβ13-β14/4Ala (residues 
240-243 substituted by alanine), NTΔβ20-β21 (residues 335-358 removed), NTΔβ23-β24 (residues 
399-401 removed), NTΔβ31-β32 (residues 748-752 removed). A. Cell homogenates were 
incubated with glutaraldehyde for the indicated time points under reducing (10 mM DTT) 
conditions and analyzed by Western blotting using AbcMyc; monomer (M) and tetramer (T) are 
indicated with the arrows. B. Densitometry analysis (n ≥ 6) was carried out on the bands 
corresponding to tetramer and monomer moieties and used to calculate tetramer formation. 
Data are given as mean value ± SEM; statistical analysis was carried out using Kruskal-Wallis 
test with Dunn’s multiple comparison test. 
 
Figure 2: Aspartate 179 and aspartate 180 are indispensable for RyR2 N-terminus 
tetramerization 
Chemical cross-linking assays (n = 8) of NTWT, NTK167A+Q168A, NTE173A+K174A and 
NTD179A+D180A as described in the legend to Figure 1. Data are given as mean value ± SEM; 
statistical analysis was carried out using Kruskal-Wallis test with Dunn’s multiple comparison 
test. 
 
Figure 3: The β8-β9 loop is dispensable for RyR2 N-terminus interaction with C-terminus 
Co-immunoprecipitation assays from HEK293 cells co-expressing NTWT or NTΔβ8-β9 together 
with HA-tagged RyR2-CT (residues 3529-4967) in the presence of 1 mM EGTA or 100 μM 
CaCl2 as indicated. A. HA-RyR2-CT was immunoprecipitated with AbHA from CHAPS-
solubilized cell lysates and the presence of co-precipitated NTWT/NTΔβ8-β9 was analyzed by 
Western blotting using AbcMyc (top). To detect immuno-isolated HA-RyR2-CT, 1/10th of IP 
samples was analyzed by Western blotting using AbHA (bottom). Non-immune rabbit IgG 
served as negative control (non-specific binding). An aliquot of HEK293 cell lysate 
corresponding to 1% of the amount processed in the co-IP assay was included in the gels to 
assess protein expression. B. Data summary (n = 6) for NT specific binding (non-immune IgG 
IP signal subtracted from anti-HA IP signal) following densitometry analysis and 
normalization to each construct’s respective lysate (taken as 100%). Data are given as mean 
value ± SEM.; statistical analysis was carried out using one-way Anova with Bonferroni's 
multiple comparisons test. 
 
Figure 4: Deletion of the β8-β9 loop impairs RyR2 oligomerization 
Protein distribution profile of RyR2WT and RyR2Δβ8-β9 assessed by sucrose density gradient 
centrifugation. A. RyR2WT and RyR2Δβ8-β9 were expressed in HEK293 cells, CHAPS-
solubilized microsomal membranes were subjected to density gradient centrifugation and 
collected sucrose fractions were analyzed by Western blotting using RyR2 Ab1093. Microsomes 
(25 g, M) were also included to assess protein expression; sucrose concentration as indicated. 
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B. Cumulative data (n = 4) following densitometry analysis and normalization against the 
amount of input protein in the microsomes; data are given as mean value ± SEM. 
 
Figure 5: RyR2Δβ8-β9 displays drastically altered intracellular Ca2+ release dynamics 
Single cell Ca2+ imaging using confocal laser scanning microscopy to monitor spontaneous 
Ca2+ release transient events. A. Traces from Fluo-3 loaded single HEK293 cells expressing 
RyR2WT or RyR2Δβ8-β9 showing spontaneous Ca2+ transients and Ca2+ release induced by 
caffeine (1 mmol/L, 10 mmol/L) or thapsigargin (1 μmol/L). B. Ca2+ transient characteristics 
including amplitude, duration and frequency of events were analyzed for 84 cells expressing 
RyR2WT and 81 cells expressing RyR2Δβ8-β9 from 4 separate experiments, whereas the caffeine 
response for at least 20 cells. The ER Ca2+ store content was measured by integration of the (1 
μmol/L) thapsigargin-induced Ca2+ release (following 1 mmol/L caffeine application) at the 
end of each experiment. Data are normalized for RyR2WT and expressed as mean value ± SEM; 
statistical analysis was carried out using Mann-Whitney test. 
 
Figure 6: The pathogenic R176Q mutation decreases N-terminus tetramerization but it has no 
effect on N-terminus interaction with C-terminus or RyR2 tetramer assembly 
A. Chemical cross-linking assays (n = 8) of NTWT and NTR176Q as described in the legend to 
Figure 1. Data are given as mean value ± SEM; statistical analysis was carried out using Mann-
Whitney test. 
B. Co-immunoprecipitation assays (n ≥ 8) of HA-RyR2-CT with NTWT or NTR176Q as described 
in the legend to Figure 3. Data are given as mean value ± SEM; statistical analysis was carried 
out using Student’s t-test. 
C. Sucrose density gradient centrifugation (n = 4) of RyR2WT and RyR2R176Q as described in 
the legend to Figure 4; data are given as mean value ± SEM. 
 
Figure 7: RyR2R176Q displays hypersensitive channel characteristics 
Single cell Ca2+ imaging using confocal laser scanning microscopy to monitor spontaneous 
Ca2+ release transient events in HEK293 cells expressing RyR2WT or RyR2R176Q as described 
in the legend to Figure 5. Data from 66 cells expressing RyR2WT and 222 cells expressing 
RyR2R176Q from 4 separate experiments, are normalized for RyR2WT and expressed as mean 
value ± SEM; statistical analysis was carried out using Mann-Whitney test. 
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